HCA Healthcare Inc., through its wholly owned subsidiary HCA Inc., has established a new commercial paper program as of June 10, 2025. This program allows HCA Inc. to issue unsecured commercial paper notes with a maximum aggregate principal amount of $4.0 billion outstanding at any time. These notes are unconditionally guaranteed by HCA Healthcare Inc. The program allows for borrowing, repayment, and reborrowing of funds, with maturities not exceeding 397 days from the date of issue. The proceeds from these notes will be utilized for general corporate purposes. The notes will be sold on a private placement basis in the U.S. commercial paper market and are not registered under the Securities Act of 1933.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.